Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Diploma in Anaesthesia > Asthma and COPD > Flashcards

Asthma and COPD Flashcards

1
Q

Summarize the pathophysiological mechanisms in asthma

A

Reversible airflow obstruction due to constriction of smooth muscle in the airways
Bronchial wall inflammation leading to mucus hypersecretion and plugging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List common acute asthma precipitants

A 
Viral infection
Allergen (dust/pets/pollution/cigarette smoke)
Exercise
Emotional stress
Cold temperature
Night time
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Define airflow obstruction in the small airways

A

Airflow obstruction is defined as a FEV1/FVC (measured with spirometry) of <70 %.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What constitutes ‘reversibility’ in bronchodilator response tests for asthma

A

Post-bronchodilator (10 mins) FEV1 increases more than 200 mL and the increase is greater than 12%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Classify asthma severity based on % predicted PEFR

A

Life threatening asthma <33 %
Acute severe asthma 33-50 %
Moderate asthma >50-75 %
Mild asthma >75 %

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Define ‘control’ of asthma

A 
No day time symptoms
No night time awakening due to asthma
No exacerbations
No need for rescue treatment
No limitations to activity

There may have to be compromise between side effects of treatment and control of symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the step-wise approach to asthma management

A

Step 1: Salbutamol

Step 2: Salbutamol + Budesonide

Step 3: Salbutamol + Budesonide + Salmeterol (or increased dose of steroid inhaler)

Step 4: As step 3 but trial of high dose inhaled steroid. Consider 4th drug e.g. leukotriene receptor antagonist

Step 5: As step 4 but regular oral steroids at lowest possible dose. Specialist care required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List three different types of inhalers

A

pressurized meter dose inhaler (pmdi),
breath activated inhalers
dry powder inhalers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How do spacers improve drug delivery

A

Remove the need for coordination between activation and inhalation

Reduce the velocity of aerosol and subsequent impaction on oropharynx.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What particle size of nebulized solution is appropriate for the treatment of asthma

A

A drug particle size of 1-5 microns

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Should NSAIDS be excluded in all asthmatics

A

Only 10 % of asthmatics get bronchoconstriction secondary to NSAIDs, therefore it is unnecessary to exclude this useful group of analgesics in all asthmatics.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the criteria that define severe asthma

A

Severe asthma consists of one or more of the following:

Previous near fatal asthma e.g. requiring ventilation
Previous admission for asthma within the previous year
Requires >3 classes of asthma medication
Heavy use of beta-2 agonist
Repeated attendances at A&E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which commonly used anaesthetic drugs cause histamine release

A

Morphine (give it slowly
SUX
Thiopental
Mivacurium

Avoid in brittle asthmatics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the appearance of the capnograph tracing in asthmatics and why

A

Up-sloping of the plateau (shark fin like) –> indicates alveoli emptying at different rates.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The expiratory time might need to be prolonged in asthmatics –> what impact does this have on other ventilatory parameters

A

Decreased inspiratory time –> increased inspiratory pressures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Summarize an approach to laryngospasm, bronchospasm, poor ventilatory effort and pneumothorax

A

LARYNGOSPASM

Dx - RDS/Stridor/tug/accessory muscles/paradoxical breathing
Rx - Jaw thrust 100% O2 –> CPAP –> Re-intubation

BRONCHOSPASM
Dx - Expiratory wheeze and prolonged expiration
Rx - FiO2 1.0 and BDs

POOR VENTILATORY EFFORT
Dx - Residual sedation/opioids/incomplete recovery from NMB
Rx - BVM with FiO2 1.0 may need re-intubation
(re-sedate in the instance of residual NMB)

PNEUMOTHORAX
Rx - ICD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How is intra-operative bronchospasm diagnosed

A

Increased airway pressures with difficulty ventilating and upsloping of the capnograph trace ± desaturation

Expiratory wheeze on auscultation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How is intraoperative bronschospasm managed

A

IMMEDIATE
FiO2 1.0 and call for help
Exclude circuit malfunction/obstruction
Increase [volatile]
High Paw may be needed with I:E 1:4
Consider disconnection to relieve accumulation of autoPEEP
Change LMA to ETT if high pressures required (Aintree fibre-optic).
Drugs:
- B2 agonist puffed into circuit via adaptor or 2.5 - 5 mg salbutamol nebulized into circuit
- If equipment not available: Salbutamol 0.25 mg IV slow IV bolus

SHORT TERM
Aminophylline: 5mg/kg IV over 20 mins
(If on regular aminophylline: 0.5mg/kg/hr)
Hydrocortisone: 100mg IV
Magnesium Sulfate: 2 g in 200 ml over 20 mins
Adrenalin 10ug boluses IV
Ketamine 2mg/kg IV
ABG/CXR

DEFINITIVE
If refractory use IV infusion –> ICU

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Define COPD

A

Chronic obstructive pulmonary disease is characterized by a progressive development of airflow limitation that is not fully reversible. Clinically, it encompasses:

Chronic bronchitis ‏
Emphysema
Mucous plugging

20
Q

What is chronic bronchitis

A

Presence of productive cough for >3 months for >2 consecutive years.

21
Q

What is chronic bronchitis

A

Enlargement of air spaces, destruction of lung parenchyma, loss of lung elasticity and closure of small airways.

22
Q

What is mucous plugging

A

Due to bronchial hypersecretion, tenacious secretions and ciliary dysfunction.

23
Q

List the risk factors for the development of COPD

A
  1. Cigarette smoking
  2. Climate and air pollution
  3. Occupational exposure: Grain/coal/mineral dust/welding fumes
  4. Alpha 1 - antitrypsin deficiency
24
Q

What differences are there between asthma and COPD?

A 
Entity - COPD - Asthma
Age - > 35 - Any age
Cough - Persistent + Productive - Intermittent and dry
Smoking - Almost invariable - Possible
Breathlessness - Progressive and persistent - Intermittent and variable
Nocturnal Sx - Uncommon - Common
Family Hx - Uncommon - common
Atopy - Possible - common
25
Q

What is the purpose of prn reliever inhalers in COPD

A

Improve exercise tolerance and relieve dyspnoea

26
Q

When are long acting beta agonists indicated in COPD

A

If patients remain symptomatic despite prn reliever inhalers a long acting inhaled beta agonist or anticholinergic is added

27
Q

Describe two different methods of inhaler delivery

A

Metered-dose inhaler (usually with spacer)

Breath-activated inhaler

28
Q

What and when are oral medications prescribed

A

Oral steroids used for acute exacerbations
Severe uncontrolled COPD might warrant maintenance steroids

Oral theophylline is used for more severe COPD

Mucolytics in chronic bronchitis

29
Q

When are home nebulizers prescribed

A

For patients with disabling breathlessness and whose disease is uncontrolled on inhalers

30
Q

What are the benefits of home oxygen

A
  1. Improve survival
  2. Reduce incidence of polycythaemia
  3. Reduce progression of pulmonary hypertension
  4. Improve neuropsychological health
31
Q

How is home oxygen prescribed

A

Continuous therapy with O2 concentrator > 15 hours/day

Intermittent therapy for short bursts using O2 cylinders

32
Q

Who is prescribed home O2 therapy

A

Marked breathlessness at rest with PaO2 < 7.3 kPa

33
Q

List the non-pharmacological management of patient’s with COPD

A
  1. Smoking cessation
  2. Pulmonary rehabilitation
    - exercise
    - nutritional
  3. Immunization - Pneumococcus and influenza
  4. Surgery - bullectomy and lung volume reduction surgery in patients with emphysema
34
Q

List the benefits of smoking cessation

A
  1. Improvement of oxygen carrying capacity due to decrease in COHb (12 - 18 hours)
  2. Return to normal hepatic enzyme function (6 - 8 weeks)
  3. Return to normal immune function (6 - 8 weeks)
  4. Improvement of ciliary and airway function and decreased sputum production
35
Q

What should be considered in the perioperative period if the patient is on maintenance steroid therapy (>10mg daily)

A

Perioperative steroid replacement - IV hydrocortisone

Ensure usual prednisone is taken and that regular dosing in the postoperative period

36
Q

What surgical factors might increase the risk of pulmonary complications

A
  1. The closer the incision is to the diaphragm –> hypoventilation and pulmonary complications
    (greatest risk for thoracic and upper abdominal surgery)
  2. Postoperative pulmonary complications are lower for laparoscopic versus open surgery
  3. Increased risk with increased surgical durations
37
Q

What are the advantages of regional anaesthesia in COPD

A

Allows maintenance of spontaneous ventilation without irritation of airway

Opioid sparing effect

May facilitate early mobilization

38
Q

What are the disadvantages of regional anaesthesia in COPD

A

Patient preference:
- Can patient lie flat and still for duration of surgery

Is sedation required to facilitate regional technique –> respiratory depression

Neuraxial blocks - Sensory level of T6 may compromise intercostal muscle function: reduce coughing efficacy

Pneumothorax risk with supraclavicular approaches to the brachial plexus and interscalene approach to the phrenic nerve

39
Q

What are the advantages of GA in COPD

A
  1. Control of ventilation and ETCO2
  2. May be necessary for certain types of surgery
  3. ETT - definitive airway and allows for suction of secretions
  4. May be required to maintain oxygenation in the face of respiratory depression
40
Q

What are the disadvantages of GA in COPD

A

Changes in functional lung volumes –> compromise postoperative resp function in patients with reduced respiratory reserve

Bronchospasm risk from airway instrumentation and histamine releasing drugs

Risk of barotrauma and pneumothorax from IPPV/PEEP/Air trapping

Need to avoid N2O in bullous emphysema due to the risk of rupturing a bullae

41
Q

Why is vascular access a challenge in patients on long term steroids

A

Fragile skin and vessel walls

42
Q

How should drug choices be guided in COPD

A 
Avoid drugs that cause histamine release
Morphine
Mivacurium
SUX
Thiopental
43
Q

How are important lung capacities affected by anaesthesia and surgery

A

Vital capacity and functional residual capacity are reduced subsequent to the effects of anaesthetic drugs, neuromuscular blocking agents and surgical trauma

44
Q

What measures are available to help preserve respiratory function and oxygentation

A

Lung expansion manoeuvres (teach prior to surgery)

  • sitting
  • deep breathing
  • Incentive spirometry (inhalation)
  • positive pressure breathing techniques (exhalation)

Chest physiotherapy‏
Humidified Oxygen therapy, CPAP, nebs, analgesia/RA, (coughing and deep breathing)

45
Q

How is the need for perioperative steroid replacement assessed

A

Depends on the dose of long term steroids (>10 mg prednisolone)

Depends on whether surgery is minor, intermediate or major

46
Q

Can histamine antagonists reduce the effects of histamine releasing drugs in patients with COPD

A

NO

Diploma in Anaesthesia (73 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions